Donald W. DeGolyer - 01 Oct 2023 Form 3 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ Jennifer Lynn Fox, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
01 Oct 2023
Net transactions value
$0
Form type
3
Filing time
05 Oct 2023, 19:01:41 UTC
Previous filing
16 Sep 2022
Next filing
05 Oct 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EBS Common Stock 0 01 Oct 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit list: Ex 24.1 - Power of Attorney